CODX Net Invested Capital from 2010 to 2024

CODX Stock  USD 1.01  0.05  4.72%   
Co Diagnostics Net Invested Capital yearly trend continues to be fairly stable with very little volatility. Net Invested Capital will likely drop to about 64.1 M in 2024. Net Invested Capital is the total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents. View All Fundamentals
 
Net Invested Capital  
First Reported
2010-12-31
Previous Quarter
86 M
Current Value
64.1 M
Quarterly Volatility
46.8 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Co Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Co Diagnostics' main balance sheet or income statement drivers, such as Interest Expense of 18 M, Selling General Administrative of 15 M or Total Revenue of 6.5 M, as well as many indicators such as Price To Sales Ratio of 5.44, Dividend Yield of 0.0 or PTB Ratio of 0.43. CODX financial statements analysis is a perfect complement when working with Co Diagnostics Valuation or Volatility modules.
  
Check out the analysis of Co Diagnostics Correlation against competitors.
For more information on how to buy CODX Stock please use our How to Invest in Co Diagnostics guide.

Latest Co Diagnostics' Net Invested Capital Growth Pattern

Below is the plot of the Net Invested Capital of Co Diagnostics over the last few years. It is the total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents. Co Diagnostics' Net Invested Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Co Diagnostics' overall financial position and show how it may be relating to other accounts over time.
Net Invested Capital10 Years Trend
Slightly volatile
   Net Invested Capital   
       Timeline  

CODX Net Invested Capital Regression Statistics

Arithmetic Mean33,282,207
Geometric Mean9,414,000
Coefficient Of Variation140.62
Mean Deviation39,924,119
Median3,850,524
Standard Deviation46,801,585
Sample Variance2190.4T
Range133.6M
R-Value0.74
Mean Square Error1062.7T
R-Squared0.55
Significance0
Slope7,757,636
Total Sum of Squares30665.4T

CODX Net Invested Capital History

202464.1 M
202386 M
2022114.5 M
2021134.5 M
202066.7 M
20191.7 M
2018849.8 K

About Co Diagnostics Financial Statements

Co Diagnostics investors use historical fundamental indicators, such as Co Diagnostics' Net Invested Capital, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Co Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Invested Capital86 M64.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for CODX Stock Analysis

When running Co Diagnostics' price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.